| Year |
Citation |
Score |
| 2021 |
Fudim M, Ponikowski P, Burkhoff D, Dunlap M, Sobotka PA, Molinger J, Patel MR, Felker GM, Hernandez AF, Litwin SE, Borlaug BA, Bapna A, Sievert H, Reddy VY, Engelman ZJ, et al. Splanchnic Nerve Modulation in Heart Failure: Mechanistic Overview, Initial Clinical Experience, and Safety Considerations. European Journal of Heart Failure. PMID 33886137 DOI: 10.1002/ejhf.2196 |
0.387 |
|
| 2019 |
Dunlap ME, Kinugawa T, Sica DA, Thames MD. Cardiopulmonary baroreflex control of renal sympathetic nerve activity is impaired in dogs with left ventricular dysfunction. Journal of Cardiac Failure. PMID 31449963 DOI: 10.1016/J.Cardfail.2019.08.012 |
0.457 |
|
| 2017 |
Tang WHW, Dunlap ME. Reconsidering Renal Sympathetic Denervation for Heart Failure. Jacc. Basic to Translational Science. 2: 282-284. PMID 30062149 DOI: 10.1016/J.Jacbts.2017.05.003 |
0.496 |
|
| 2017 |
Dunlap ME, Hauptman PJ, Amin AN, Chase SL, Chiodo JA, Chiong JR, Dasta JF. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry). Journal of the American Heart Association. 6. PMID 28775063 DOI: 10.1161/Jaha.116.005261 |
0.49 |
|
| 2017 |
Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, et al. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. Jacc. Heart Failure. 5: 1-13. PMID 28034373 DOI: 10.1016/J.Jchf.2016.09.012 |
0.435 |
|
| 2017 |
Pattanshetty DJ, Cook D, Sharma D, Dunlap ME. Heart Failure Patients with Reduced Ejection Fraction Have Higher Prevalence of Cognitive Impairment Despite Normal MMSE Journal of Cardiac Failure. 23: S68. DOI: 10.1016/J.Cardfail.2017.07.191 |
0.472 |
|
| 2016 |
Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, et al. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From ASCEND-HF. Jacc. Heart Failure. PMID 28017346 DOI: 10.1016/j.jchf.2016.09.012 |
0.326 |
|
| 2016 |
Vallakati A, Reddy S, Dunlap ME, Taylor DO. Impact of Statin Use After Heart Transplantation: A Meta-Analysis. Circulation. Heart Failure. 9. PMID 27729391 DOI: 10.1161/Circheartfailure.116.003265 |
0.312 |
|
| 2016 |
Murad K, Dunlap ME. Measuring Congestion in Acute Heart Failure: the "Holy Grail" Still Awaits. Journal of Cardiac Failure. PMID 27377545 DOI: 10.1016/J.Cardfail.2016.06.424 |
0.529 |
|
| 2016 |
Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DJ, Lenihan DJ, Lindenfeld JM, et al. Clinical and Research Considerations for Patients with Hypertensive Acute Heart Failure A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. PMID 27286136 DOI: 10.1111/Acem.13025 |
0.494 |
|
| 2016 |
Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DJ, Lenihan DJ, Lindenfeld JM, et al. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Journal of Cardiac Failure. PMID 27262665 DOI: 10.1016/J.Cardfail.2016.04.015 |
0.497 |
|
| 2016 |
Metra M, Mentz RJ, Hernandez AF, Heizer GM, Armstrong PW, Clausell N, Corbalan R, Costanzo MR, Dickstein K, Dunlap ME, Ezekowitz JA, Howlett JG, Komajda M, Krum H, Lombardi C, et al. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). The American Journal of Cardiology. PMID 27108685 DOI: 10.1016/J.Amjcard.2016.03.002 |
0.391 |
|
| 2016 |
Pasala T, Golbari S, Malik S, Sengodan P, Rader F, Owan T, Tandar A, Dunlap M, Gandhi S. EFFECT OF AGE, GENDER AND CO-MORBIDITY ON CENTRAL INDICES OF AORTIC STIFFNESS IN PATIENTS UNDERGOING CARDIAC CATHETERIZATION Journal of the American College of Cardiology. 67: 1877. DOI: 10.1016/S0735-1097(16)31878-2 |
0.31 |
|
| 2015 |
Dunlap ME, Bhardwaj A, Hauptman PJ. Autonomic Modulation in Heart Failure: Ready for Prime Time? Current Cardiology Reports. 17: 103. PMID 26384110 DOI: 10.1007/S11886-015-0652-2 |
0.482 |
|
| 2015 |
Bhardwaj A, Dunlap ME. Autonomic Dysregulation as a Therapeutic Target for Acute HF. Current Treatment Options in Cardiovascular Medicine. 17: 403. PMID 26303885 DOI: 10.1007/S11936-015-0403-0 |
0.426 |
|
| 2015 |
Crissinger ME, Marchionda KM, Dunlap ME. Adherence to clinical guidelines in heart failure (HF) outpatients: Impact of an interprofessional HF team on evidence-based medication use. Journal of Interprofessional Care. 29: 483-7. PMID 26091371 DOI: 10.3109/13561820.2015.1027334 |
0.346 |
|
| 2015 |
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, et al. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 131: 1763-71. PMID 25986447 DOI: 10.1161/Circulationaha.114.014536 |
0.536 |
|
| 2015 |
Marks D, Vallakati A, Reddy S, Dunlap M. Role of β-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: A Meta-Analysis Journal of Cardiac Failure. 21: S51. DOI: 10.1016/J.Cardfail.2015.06.171 |
0.488 |
|
| 2014 |
Dunlap ME, Tang WH. Heart failure notwithstanding ejection fraction (HFnEF)--a possible unifying hypothesis? Journal of Cardiac Failure. 20: 60-2. PMID 24342257 DOI: 10.1016/J.Cardfail.2013.12.006 |
0.486 |
|
| 2014 |
Vallakati A, Sengodan P, Dunlap M. Role of Atrioventricular Junction Ablation in Patients with Atrial Fibrillation Undergoing Cardiac Resynchronization Therapy? - A Meta-Analysis Journal of Cardiac Failure. 20: S91. DOI: 10.1016/J.Cardfail.2014.06.255 |
0.3 |
|
| 2014 |
Chiong JR, Hauptman PJ, Dunlap ME, Chiodo JA, Chase SL. Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry Journal of Cardiac Failure. 20: S62-S63. DOI: 10.1016/J.Cardfail.2014.06.177 |
0.477 |
|
| 2013 |
Howlett JG, Ezekowitz JA, Podder M, Hernandez AF, Diaz R, Dickstein K, Dunlap ME, Corbalán R, Armstrong PW, Starling RC, O'Connor CM, Califf RM, Fonarow GC. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). Circulation. Cardiovascular Quality and Outcomes. 6: 534-42. PMID 23899930 DOI: 10.1161/Circoutcomes.113.000119 |
0.513 |
|
| 2013 |
Dunlap ME, Sobotka PA. Fluid re-distribution rather than accumulation causes most cases of decompensated heart failure. Journal of the American College of Cardiology. 62: 165-6. PMID 23603694 DOI: 10.1016/J.Jacc.2013.02.081 |
0.514 |
|
| 2013 |
Burchell AE, Sobotka PA, Hart EC, Nightingale AK, Dunlap ME. Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure. Current Heart Failure Reports. 10: 139-46. PMID 23504401 DOI: 10.1007/S11897-013-0135-Y |
0.48 |
|
| 2013 |
Dunlap ME, Zile M, Bensimhon D, Bittner V, Boineau R, Kraus W, Moe G, O'Connor C, Stebbins A, Wertheimer J, Whellan D. Mode of Death in Contemporary Heart Failure Patients and the Impact of Structured Exercise: Insights from the HF-ACTION Trial Journal of Cardiac Failure. 19: S27. DOI: 10.1016/J.Cardfail.2013.06.091 |
0.461 |
|
| 2012 |
Forman DE, Fleg JL, Kitzman DW, Brawner CA, Swank AM, McKelvie RS, Clare RM, Ellis SJ, Dunlap ME, Bittner V. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. Journal of the American College of Cardiology. 60: 2653-61. PMID 23177293 DOI: 10.1016/J.Jacc.2012.08.1010 |
0.459 |
|
| 2012 |
Dunlap ME, Sobotka PA. Efficiently doing the wrong thing. Journal of the American College of Cardiology. 60: 1713; author reply p. PMID 23079122 DOI: 10.1016/J.Jacc.2012.07.025 |
0.487 |
|
| 2012 |
Gunawardena S, Dunlap ME. Anemia and iron deficiency in heart failure. Current Heart Failure Reports. 9: 319-27. PMID 22940847 DOI: 10.1007/S11897-012-0112-X |
0.436 |
|
| 2012 |
Reed SD, Li Y, Dunlap ME, Kraus WE, Samsa GP, Schulman KA, Zile MR, Whellan DJ. In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial). The American Journal of Cardiology. 110: 1150-5. PMID 22762718 DOI: 10.1016/J.Amjcard.2012.05.059 |
0.343 |
|
| 2011 |
Fallick C, Sobotka PA, Dunlap ME. Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circulation. Heart Failure. 4: 669-75. PMID 21934091 DOI: 10.1161/Circheartfailure.111.961789 |
0.382 |
|
| 2011 |
Dunlap ME. Doing the right thing. Journal of the American College of Cardiology. 58: 887; author reply 88. PMID 21835333 DOI: 10.1016/J.Jacc.2011.01.069 |
0.431 |
|
| 2011 |
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, ... ... Dunlap ME, et al. Effect of nesiritide in patients with acute decompensated heart failure. The New England Journal of Medicine. 365: 32-43. PMID 21732835 DOI: 10.1056/Nejmoa1100171 |
0.503 |
|
| 2011 |
Bibevski S, Dunlap ME. Evidence for impaired vagus nerve activity in heart failure. Heart Failure Reviews. 16: 129-35. PMID 20820912 DOI: 10.1007/S10741-010-9190-6 |
0.776 |
|
| 2011 |
Ginwalla M, Rader F, Pasala T, Johnson J, Dunlap M. Pulse Pressure Widening is a Determinant of Diastolic Dysfunction Journal of Cardiac Failure. 17: S88. DOI: 10.1016/J.Cardfail.2011.06.296 |
0.301 |
|
| 2011 |
Cevasco ME, Sullivan KM, Dunlap ME. Optimal Heart Failure Management in the Outpatient Setting: Assessing Treatment by Provider Type Journal of Cardiac Failure. 17: S64. DOI: 10.1016/J.Cardfail.2011.06.233 |
0.443 |
|
| 2011 |
Khan I, Anna K, Dunlap ME. Vaccination Rates in Heart Failure: Are We Missing the Target? Journal of Cardiac Failure. 17: S67. DOI: 10.1016/J.Cardfail.2011.06.211 |
0.455 |
|
| 2010 |
Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 12: 738-45. PMID 20418272 DOI: 10.1093/Eurjhf/Hfq065 |
0.55 |
|
| 2010 |
Ladenson PW, McCarren M, Morkin E, Edson RG, Shih MC, Warren SR, Barnhill JG, Churby L, Thai H, O'Brien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, et al. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. The Journal of Clinical Endocrinology and Metabolism. 95: 1349-54. PMID 20080837 DOI: 10.1210/Jc.2009-1209 |
0.325 |
|
| 2010 |
McCarren M, Goldman S, Ohm J, Thai H, Morkin E, Ladenson PW, Edson R, Churby L, Shih M, Lavori P, Warren S, Barnhill J, O'Brien T, Anand I, Warner A, ... ... Dunlap M, et al. Response to Letter Regarding Article, “DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study” Circulation. 121. DOI: 10.1161/Cir.0B013E3181D780C6 |
0.449 |
|
| 2010 |
Siddiqi NI, Jurcevic D, Krishnan V, Dunlap ME. Sleep Apnea Is Highly Prevalent in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction Journal of Cardiac Failure. 16: S116. DOI: 10.1016/J.Cardfail.2010.06.407 |
0.427 |
|
| 2009 |
Goldman S, McCarren M, Morkin E, Ladenson PW, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O'Brien T, Anand I, Warner A, Hattler B, Dunlap M, et al. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study. Circulation. 119: 3093-100. PMID 19506112 DOI: 10.1161/Circulationaha.108.834424 |
0.457 |
|
| 2009 |
Mack S, Smith R, Dunlap ME. Systematic Heart Failure Education Improves Patient Self-Care and Self Efficacy Journal of Cardiac Failure. 15: S105. DOI: 10.1016/J.Cardfail.2009.06.134 |
0.383 |
|
| 2008 |
Hauptman PJ, Rich MW, Heidenreich PA, Chin J, Cummings N, Dunlap ME, Edwards ML, Gregory D, O'connor CM, Pezzella SM, Philbin E. The heart failure clinic: a consensus statement of the Heart Failure Society of America. Journal of Cardiac Failure. 14: 801-15. PMID 19041043 DOI: 10.1016/J.Cardfail.2008.10.005 |
0.541 |
|
| 2008 |
Rea ME, Dunlap ME. Renal hemodynamics in heart failure: implications for treatment. Current Opinion in Nephrology and Hypertension. 17: 87-92. PMID 18090676 DOI: 10.1097/MNH.0b013e3282f357da |
0.422 |
|
| 2008 |
Goldman S, McCarren M, Morkin E, Ladenson P, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O'Brien T, Anand I, Warner A, Dunlap M, Hattle B, et al. DITPA, a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial VA Cooperative Study Journal of Cardiac Failure. 14: 796. DOI: 10.1016/J.Cardfail.2008.10.008 |
0.32 |
|
| 2007 |
Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. Journal of the American College of Cardiology. 50: 1959-66. PMID 17996561 DOI: 10.1016/J.Jacc.2007.07.067 |
0.517 |
|
| 2007 |
Cutler MJ, Rosenbaum DS, Dunlap ME. Structural and electrical remodeling as therapeutic targets in heart failure. Journal of Electrocardiology. 40: S1-7. PMID 17993305 DOI: 10.1016/J.Jelectrocard.2007.05.027 |
0.45 |
|
| 2007 |
Dunlap ME. New studies influencing treatment of heart failure: 2006 update. Pharmacotherapy. 27: 3S-11S. PMID 17381369 DOI: 10.1592/phco.27.4part2.3S |
0.378 |
|
| 2007 |
Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure. 9: 83-91. PMID 17188020 DOI: 10.1016/J.Ejheart.2006.10.012 |
0.453 |
|
| 2006 |
McMurray JJ, Young JB, Dunlap ME, Granger CB, Hainer J, Michelson EL, Earle S, Olofsson B, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. American Heart Journal. 151: 985-91. PMID 16644319 DOI: 10.1016/J.Ahj.2006.02.028 |
0.443 |
|
| 2006 |
Mitchell GF, Arnold JM, Dunlap ME, O'Brien TX, Marchiori G, Warner E, Granger CB, Desai SS, Pfeffer MA. Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program. European Journal of Heart Failure. 8: 191-7. PMID 16188495 DOI: 10.1016/J.Ejheart.2005.07.006 |
0.515 |
|
| 2005 |
Boxer RS, Dunlap ME. Aldosterone antagonists in the treatment and prevention of heart failure. Current Treatment Options in Cardiovascular Medicine. 7: 431-6. PMID 16283969 DOI: 10.1007/S11936-005-0027-X |
0.553 |
|
| 2005 |
Ibrahim OA, Dunlap ME. Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers? Current Heart Failure Reports. 2: 89-93. PMID 16036056 DOI: 10.1007/S11897-005-0014-2 |
0.439 |
|
| 2005 |
Bhakta S, Dunlap ME. Treatment of heart failure with a normal ejection fraction. Current Treatment Options in Cardiovascular Medicine. 7: 317-25. PMID 16004862 DOI: 10.1007/S11936-005-0042-Y |
0.463 |
|
| 2005 |
O'Meara E, Lewis E, Granger C, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Ostergren J, Carlsson J, Olofsson B, McMurray J, Yusuf S, Swedberg K, Pfeffer MA. Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 7: 650-6. PMID 15921807 DOI: 10.1016/J.Ejheart.2005.01.021 |
0.54 |
|
| 2005 |
Osman MN, Dunlap ME. Management of heart failure with pulmonary hypertension. Current Cardiology Reports. 7: 196-203. PMID 15865861 DOI: 10.1007/S11886-005-0077-4 |
0.376 |
|
| 2005 |
Deck J, Bibevski S, Gnecchi-Ruscone T, Bellina V, Montano N, Dunlap ME. Alpha7-nicotinic acetylcholine receptor subunit is not required for parasympathetic control of the heart in the mouse. Physiological Genomics. 22: 86-92. PMID 15797970 DOI: 10.1152/Physiolgenomics.00085.2004 |
0.745 |
|
| 2005 |
Bhakta S, Dunlap ME. Treatment of heart failure with a normal ejection fraction Current Treatment Options in Cardiovascular Medicine. 7: 317-325. |
0.36 |
|
| 2004 |
Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, et al. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation. 110: 2618-26. PMID 15492298 DOI: 10.1161/01.Cir.0000146819.43235.A9 |
0.485 |
|
| 2004 |
Bhakta S, Dunlap ME. Angiotensin-receptor blockers in heart failure: evidence from the CHARM trial. Cleveland Clinic Journal of Medicine. 71: 665-73. PMID 15449762 DOI: 10.3949/Ccjm.71.8.665 |
0.546 |
|
| 2004 |
Bibevski S, Dunlap ME. Prevention of diminished parasympathetic control of the heart in experimental heart failure. American Journal of Physiology. Heart and Circulatory Physiology. 287: H1780-5. PMID 15191889 DOI: 10.1152/Ajpheart.00430.2004 |
0.765 |
|
| 2004 |
Hughes-Doichev R, Dunlap ME. Is heart failure different on the two continents (North America and Europe)? Current Cardiology Reports. 6: 182-8. PMID 15075052 DOI: 10.1007/S11886-004-0021-Z |
0.542 |
|
| 2004 |
McMurray JJ, Östergren J, Olofsson B, Granger CB, Michelson E, Young JB, Dunlap M, Yusuf S, Swedberg K, Pfeffer MA. 835-5 Candesartan improves functional class across a broad spectrum of patients with chronic heart failure: Results of the candesartan in heart failure-assessment of reduction in mortality and morbidity programme (CHARM) Journal of the American College of Cardiology. 43: A206. DOI: 10.1016/S0735-1097(04)90878-9 |
0.536 |
|
| 2004 |
McMurray JJ, Lang CC, Swedberg K, Östergren J, Granger CB, Michelson E, Young JB, Olofsson B, Dunlap M, Yusuf S, Pfeffer MA. 1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM) Journal of the American College of Cardiology. 43: A197. DOI: 10.1016/S0735-1097(04)90836-4 |
0.515 |
|
| 2004 |
Young JB, Swedberg K, Dunlap ME, Pfeffer MA, Probstfield JL, Granger CB, McKelvey RS, McMurray JJ, Michaelson EL, Olofsson B, Ostergren J, Yusuf S. Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials Journal of Cardiac Failure. 10: S76. DOI: 10.1016/J.Cardfail.2004.06.212 |
0.486 |
|
| 2003 |
Dunlap ME, Bibevski S, Rosenberry TL, Ernsberger P. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1632-40. PMID 12829433 DOI: 10.1152/Ajpheart.01051.2002 |
0.751 |
|
| 2002 |
Wallick DW, Dunlap ME, Stuesse SS, Thames MD. Denervation of vagal cardiopulmonary receptors by injection of kainic acid into the nodose ganglia in dogs. Autonomic Neuroscience : Basic & Clinical. 102: 85-9. PMID 12492140 DOI: 10.1016/S1566-0702(02)00176-5 |
0.346 |
|
| 2002 |
Peterson RC, Dunlap ME. Angiotensin II receptor blockers in the treatment of heart failure. Congestive Heart Failure (Greenwich, Conn.). 8: 246-50; 256. PMID 12368586 DOI: 10.1111/J.1527-5299.2000.01156.X |
0.492 |
|
| 2002 |
Dunlap ME, Peterson RC. ACE inhibitors vs ARBs: is one class better for heart failure. Cleveland Clinic Journal of Medicine. 69: 433-8. PMID 12022388 DOI: 10.3949/Ccjm.69.5.433 |
0.469 |
|
| 2001 |
Mitchell GF, Tardif JC, Arnold JM, Marchiori G, O'Brien TX, Dunlap ME, Pfeffer MA. Pulsatile hemodynamics in congestive heart failure. Hypertension. 38: 1433-9. PMID 11751731 DOI: 10.1161/Hy1201.098298 |
0.369 |
|
| 2000 |
Bibevski S, Zhou Y, McIntosh JM, Zigmond RE, Dunlap ME. Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5076-82. PMID 10864965 DOI: 10.1523/Jneurosci.20-13-05076.2000 |
0.694 |
|
| 1999 |
Bibevski S, Dunlap ME. Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation. 99: 2958-63. PMID 10359742 DOI: 10.1161/01.Cir.99.22.2958 |
0.776 |
|
| Show low-probability matches. |